Provider perceptions of challenges to identifying women Veterans with hazardous substance use.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
04 Mar 2022
Historique:
received: 22 08 2021
accepted: 15 02 2022
entrez: 5 3 2022
pubmed: 6 3 2022
medline: 9 3 2022
Statut: epublish

Résumé

Approximately one-third of women Veterans Health Administration (VHA) users have substance use disorders (SUD). Early identification of hazardous substance use in this population is critical for the prevention and treatment of SUD. We aimed to understand challenges to identifying women Veterans with hazardous substance use to improve future referral, evaluation, and treatment efforts. Design: We conducted a secondary analysis of semi-structured interviews conducted with VHA interdisciplinary women's SUD providers at VA Greater Los Angeles Healthcare System. Using purposive and snowball sampling we interviewed 17 VHA providers from psychology, social work, women's health, primary care, and psychiatry. Our analytic approach was content analysis of provider perceptions of identifying hazardous substance use in women Veterans. Providers noted limitations across an array of existing identification methodologies employed to identify women with hazardous substance use and believed these limitations were abated through trusting provider-patient communication. Providers emphasized the need to have a process in place to respond to hazardous use when identified. Provider level factors, including provider bias, and patient level factors such as how they self-identify, may impact identification of women Veterans with hazardous substance use. Tailoring language to be sensitive to patient identity may help with identification in women Veterans with hazardous substance use or SUD who are not getting care in VHA but are eligible as well as those who are not eligible for care in VHA. To overcome limitations of existing screening tools and processes of identifying and referring women Veterans with hazardous substance use to appropriate care, future efforts should focus on minimizing provider bias, building trust in patient-provider relationships, and accommodating patient identities.

Sections du résumé

BACKGROUND BACKGROUND
Approximately one-third of women Veterans Health Administration (VHA) users have substance use disorders (SUD). Early identification of hazardous substance use in this population is critical for the prevention and treatment of SUD. We aimed to understand challenges to identifying women Veterans with hazardous substance use to improve future referral, evaluation, and treatment efforts.
METHODS METHODS
Design: We conducted a secondary analysis of semi-structured interviews conducted with VHA interdisciplinary women's SUD providers at VA Greater Los Angeles Healthcare System.
PARTICIPANTS METHODS
Using purposive and snowball sampling we interviewed 17 VHA providers from psychology, social work, women's health, primary care, and psychiatry.
APPROACH METHODS
Our analytic approach was content analysis of provider perceptions of identifying hazardous substance use in women Veterans.
RESULTS RESULTS
Providers noted limitations across an array of existing identification methodologies employed to identify women with hazardous substance use and believed these limitations were abated through trusting provider-patient communication. Providers emphasized the need to have a process in place to respond to hazardous use when identified. Provider level factors, including provider bias, and patient level factors such as how they self-identify, may impact identification of women Veterans with hazardous substance use. Tailoring language to be sensitive to patient identity may help with identification in women Veterans with hazardous substance use or SUD who are not getting care in VHA but are eligible as well as those who are not eligible for care in VHA.
CONCLUSIONS CONCLUSIONS
To overcome limitations of existing screening tools and processes of identifying and referring women Veterans with hazardous substance use to appropriate care, future efforts should focus on minimizing provider bias, building trust in patient-provider relationships, and accommodating patient identities.

Identifiants

pubmed: 35246113
doi: 10.1186/s12913-022-07640-z
pii: 10.1186/s12913-022-07640-z
pmc: PMC8895644
doi:

Substances chimiques

Hazardous Substances 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

300

Subventions

Organisme : quality enhancement research initiative
ID : CDA 11-261

Informations de copyright

© 2022. The Author(s).

Références

Ann Med. 2021 Dec;53(1):1989-1992
pubmed: 34751058
Am J Addict. 2018 Mar;27(2):97-100
pubmed: 29489045
J Interpers Violence. 2014 May;29(7):1318-37
pubmed: 24255069
Psychol Trauma. 2021 Oct;13(7):814-823
pubmed: 33764096
EBioMedicine. 2015 Sep 02;2(10):1394-404
pubmed: 26629534
Am J Addict. 1997 Fall;6(4):273-83
pubmed: 9398925
Alcohol Alcohol. 2002 May-Jun;37(3):261-8
pubmed: 12003915
Psychiatr Serv. 2003 Feb;54(2):214-8
pubmed: 12556603
Psychiatr Clin North Am. 2010 Jun;33(2):339-55
pubmed: 20385341
Alcohol Clin Exp Res. 2005 May;29(5):844-54
pubmed: 15897730
J Subst Abuse Treat. 2017 Oct;81:11-16
pubmed: 28847450
Emerg Med Int. 2018 May 17;2018:2306587
pubmed: 29888006
Acad Psychiatry. 2016 Jun;40(3):454-60
pubmed: 25749922
J Addict Dis. 2013;32(2):119-39
pubmed: 23815420
J Midwifery Womens Health. 2013 May-Jun;58(3):278-87
pubmed: 23631601
Drug Alcohol Depend. 2013 Jul 1;131(1-2):23-35
pubmed: 23490450
Int J Drug Policy. 2021 Jul;93:103236
pubmed: 33838990
BMC Health Serv Res. 2010 May 26;10:137
pubmed: 20504307
JAMA Netw Open. 2019 Nov 1;2(11):e1914135
pubmed: 31722020
J Gen Intern Med. 2006 Jun;21(6):652-5
pubmed: 16808752
Alcohol Clin Exp Res. 2015 Jan;39(1):158-65
pubmed: 25623414
Addict Behav. 2014 Feb;39(2):379-85
pubmed: 23498717
J Fam Issues. 2018 Jan;39(1):3-27
pubmed: 29307947
Drug Alcohol Depend. 2014 Mar 1;136:1-10
pubmed: 24315571
Health Serv Res. 2005 Jun;40(3):781-810
pubmed: 15960691
Drug Alcohol Depend. 2021 Aug 1;225:108791
pubmed: 34098384
Glob Public Health. 2008;3 Suppl 1:90-103
pubmed: 19288345
J Adv Nurs. 1997 Sep;26(3):623-30
pubmed: 9378886
Drug Alcohol Rev. 2006 Nov;25(6):515-36
pubmed: 17132571
J Pers Soc Psychol. 2007 Dec;93(6):1011-27
pubmed: 18072851

Auteurs

Karleen F Giannitrapani (KF)

Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, Palo Alto, CA, United States of America. Karleen@stanford.edu.
Department of Primary Care and Population Health, School of Medicine, Stanford University, Palo Alto, CA, United States of America. Karleen@stanford.edu.

Jesse R Holliday (JR)

Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, Palo Alto, CA, United States of America.

Andrew W Dawson (AW)

Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, Palo Alto, CA, United States of America.
Mind and Society Center, Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, United States of America.

Alexis K Huynh (AK)

Center for the Study of Healthcare Innovation, Implementation & Policy, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.

Alison B Hamilton (AB)

Center for the Study of Healthcare Innovation, Implementation & Policy, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
Department of Psychiatry and Behavioral Science, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States of America.

Christine Timko (C)

Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, Palo Alto, CA, United States of America.
Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Palo Alto, CA, United States of America.

Katherine J Hoggatt (KJ)

San Francisco VA Health Care System, San Francisco, CA, United States of America.
Department of Medicine, University of California San Francisco, San Francisco, CA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH